证券之星消息，根据天眼查APP-财产线索数据整理，根据山东中医药大学附属眼科医院12月4日发布的 《山东中医药大学附属眼科医院医保HIS系统接口项目单一来源公示》内容显示，卫宁健康科技集团股 份有限公司中标，详情如下： 标题：山东中医药大学附属眼科医院医保HIS系统接口项目单一来源公示 通过天眼查大数据分析，卫宁健康科技集团股份有限公司共对外投资了50家企业，参与招投标项目 10069次；财产线索方面有商标信息124条，专利信息519条，著作权信息545条；此外企业还拥有行政许 可24个。 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 采购方：山东中医药大学附属眼科医院 供应商：卫宁健康科技集团股份有限公司 中标金额：250000.0 地区：山东省 发布日期：2025-12-04 ...

采购方：江门市人民医院 供应商：卫宁健康科技集团股份有限公司 中标金额：248800.0,5000,5000,1000000,5000000,10000000,50000000,50000000,5000.00 地区：广东省 发布日期：2025-12-01 通过天眼查大数据分析，卫宁健康科技集团股份有限公司共对外投资了50家企业，参与招投标项目 10069次；财产线索方面有商标信息124条，专利信息519条，著作权信息545条；此外企业还拥有行政许 可24个。 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，根据天眼查APP-财产线索数据整理，根据江门市人民医院12月1日发布的《江门市人民 医院医保智能审核系统采购项目成交结果公告》内容显示，卫宁健康科技集团股份有限公司中标，详情 如下： 标题：江门市人民医院医保智能审核系统采购项目成交结果公告 ...

Core Insights - The core point of the article is that Weining Health Technology Group Co., Ltd. has won a bid for a project related to medical core system information monitoring, medical insurance settlement reform, and maternity insurance interface reform, with a contract amount of 151 million [1][2]. Company Overview - Weining Health Technology Group Co., Ltd. has invested in a total of 50 enterprises and participated in 10,069 bidding projects [1]. - The company holds 124 trademark registrations, 519 patents, and 545 copyright registrations, indicating a strong intellectual property portfolio [1]. Project Details - The procurement was conducted by Binzhou Central Hospital, located in Shandong Province, and the announcement was made on November 27, 2025 [2].

证券日报网讯 12月1日，卫宁健康在互动平台回答投资者提问时表示，根据中国结算深圳分公司下发的 最新数据，截至2025年11月28日公司股东户数为113，356户。 （文章来源：证券日报） ...

Core Insights - The DRG/DIP concept sector experienced a decline of 0.89%, ranking among the top losers in the market [1] - Notable stocks within the sector included Langchao Software, Jiayuan Technology, and Digital Certification, which saw significant declines, while Shichuang Medical, Taiji Co., and Saili Medical were among the few that increased in value [1] Market Performance - The top-performing concept sectors included Smart Speakers (+3.71%), AI Phones (+3.39%), and Zinc Metals (+2.86%), while the DRG/DIP sector was among the laggards with a decline of 0.89% [2] - The DRG/DIP sector faced a net outflow of 311 million yuan, with 17 stocks experiencing net outflows, and 9 stocks seeing outflows exceeding 10 million yuan [2] Key Stocks and Fund Flow - Langchao Software led the outflow with a net withdrawal of 148 million yuan, followed by Rongke Technology and Shichuang Medical with outflows of 53.22 million yuan and 32.94 million yuan, respectively [2][3] - Conversely, Taiji Co., Weining Health, and Guoxin Health were the top gainers in terms of net inflow, attracting 41.91 million yuan, 16.34 million yuan, and 7.48 million yuan, respectively [2] Detailed Stock Movements - Langchao Software saw a decline of 6.01% with a turnover rate of 22.29% and a net outflow of 147.51 million yuan [2][3] - Other notable declines included Rongke Technology (-2.50%), Shichuang Medical (+4.18%), and Donghua Software (-0.20%) [2][3] - Taiji Co. and Weining Health showed positive movements with increases of 1.60% and 1.28%, respectively, while Guoxin Health remained stable with a slight decrease of 0.20% [2][3]

Core Viewpoint - Weining Health's stock has shown fluctuations in recent trading sessions, with a year-to-date increase of 22.74% but a decline over the last 60 days of 12.91% [1] Financial Performance - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion yuan, a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million yuan, reflecting a significant decline of 256.10% [2] - Cumulative cash dividends since the A-share listing amount to 455 million yuan, with 97.226 million yuan distributed over the last three years [3] Shareholder Structure - As of November 20, 2025, the number of Weining Health's shareholders decreased by 1.51% to 112,400, while the average circulating shares per person increased by 1.53% to 17,039 shares [2] - The top ten circulating shareholders include notable funds such as Huabao Zhongzheng Medical ETF and Yifangda Growth Mixed A, with some shareholders reducing their stakes [3] Stock Market Activity - On December 1, Weining Health's stock price reached 8.77 yuan per share, with a trading volume of 312 million yuan and a turnover rate of 1.89% [1] - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on February 7 [1] Business Overview - Weining Health, established on April 7, 2004, and listed on August 18, 2011, specializes in medical software development, sales, and technical services, providing comprehensive solutions for the healthcare industry's information technology needs [1] - The company's revenue composition includes 84.65% from software and services, 7.89% from hardware sales, and 7.46% from internet healthcare [1] Industry Classification - Weining Health is classified under the Shenwan industry category of Computer-Software Development-Vertical Application Software, and is associated with concepts such as AI models, domestic software, Alibaba Cloud, and DRG concepts [1]

Group 1 - The core point of the article is that Weining Health (SZ 300253) announced the convening of its 23rd meeting of the sixth board of directors on November 25, 2025, to discuss the election of the vice chairman of the board [1] - For the first half of 2025, Weining Health's revenue composition was 92.54% from the healthcare information technology sector and 7.46% from the internet healthcare sector [1] - As of the report date, Weining Health's market capitalization was 19.5 billion yuan [1] Group 2 - The article also mentions that another company, which recently went public, is under investigation by the China Securities Regulatory Commission due to a significant loss exceeding 100 million yuan and a major client reducing procurement [1]

2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议； 3、中小投资者是指除上市公司董事、监事、高级管理人员以及 单独或者合计持有公司 5%以上股份的股东以外的其他股东。 证券代码：300253 证券简称：卫宁健康 公告编号：2025-094 卫宁健康科技集团股份有限公司 参加本次会议的股东及股东代表（包括委托代理人）对会议议案 进行了审议，通过了以下议案： 《关于选举公司第六届董事会非独立董事的议案》 表决结果：同意 357,495,517 股，占出席会议股东有效表决权股 份总数的 99.6248%；反对 1,027,471 股，占出席会议股东有效表决 权股份总数的 0.2863%；弃权 319,129 股，占出席会议股东有效表决 权股份总数的 0.0889%。本议案获得通过。 一、会议召开和出席情况 卫宁健康科技集团股份有限公司（以下简称"公司"）董事会于 2025 年 11 月 10 日以公告形式发布了《关于召开 2025 年 ...

一、会议以 7 票同意、0 票反对、0 票弃权的结果审议通过了《关 于董事会会议豁免通知时限的议案》。 证券代码：300253 证券简称：卫宁健康 公告编号：2025-095 卫宁健康科技集团股份有限公司 第六届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 卫宁健康科技集团股份有限公司（以下简称"公司"）于 2025 年11月 25日在公司会议室以现场和通讯方式召开了第六届董事会第 二十三次会议。经全体董事同意豁免会议通知时限的要求，以电话、 口头的方式发出。会议应出席董事 7 人，实际出席董事 7 人。本次董 事会的召集和召开符合《中华人民共和国公司法》和《公司章程》的 规定。会议由董事长刘宁主持，公司高级管理人员列席了本次董事会。 经与会董事表决，形成决议如下： 经审议，同意豁免公司第六届董事会第二十三次会议的通知期限， 并于 2025 年 11 月 25 日召开第六届董事会第二十三次会议。 二、会议以 7 票同意、0 票反对、0 票弃权的结果审议通过了《关 于选举公司第六届董事会副董事长的议案》。 根据《公司章程》的规定， ...

上海市广发律师事务所 关于卫宁健康科技集团股份有限公司 2025 年第二次临时股东会的法律意见书 致：卫宁健康科技集团股份有限公司 卫宁健康科技集团股份有限公司（以下简称"公司"）2025 年第二次临时 股东会于 2025 年 11 月 25 日在上海市静安区寿阳路 99 弄 9 号卫宁健康大厦 16 楼会议室召开。上海市广发律师事务所经公司聘请，委派陈洁律师、成赟律师出 席现场会议，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上 市公司股东会规则》（以下简称"《股东会规则》"）等法律法规、其他规范性 文件以及《卫宁健康科技集团股份有限公司章程》（以下简称"《公司章程》"） 的规定，就本次股东会的召集和召开程序、召集人及出席会议人员的资格、会议 议案、表决方式和表决程序、表决结果和会议决议等出具本法律意见书。 为出具本法律意见书，本所律师对本次股东会所涉及的有关事项进行了审查， 查阅了相关会议文件，并对有关问题进行了必要的核查和验证。 公司已向本所保证和承诺，公司向本所律师所提供的文件和所作的陈述和说 明是完整的、真实的和有效的，有关原件及其上面的签字和印章是真实的，且一 切足以影响本法律意见书 ...